UBS Group

UBS Group’s Savara SVRA Stock Holding History

UBS Group’s Portfolio SVRA Stock Details SVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-250	Closed	-$8K	–	8803
2015 Q1	$8K	Sell	250 -120	-32%	-$4.17K	﹤0.01%	7828
2014 Q4	$15K	Buy	+370	New	+$12.9K	﹤0.01%	8030

Other funds holding SVRA

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

UBS Group's SVRA Position: Q1 2026 in Review

UBS Group increased its Savara (SVRA) stake by 194% in Q1 2026, buying an estimated $2.19M and bringing the position to 596,715 shares worth $3.26M. The position accounts for ﹤0.01% of the portfolio, ranked #4509.

UBS Group first reported a position in SVRA in Q4 2014 and has held it in 44 quarters since. 186 funds tracked by Wall St. Rank hold SVRA as of Q1 2026.

UBS Group held 596,715 shares of Savara worth $3.26M as of Q1 2026.
UBS Group bought 393,832 Savara shares in Q1 2026, an estimated $2.19M.
Savara made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #4509 holding.
UBS Group first reported a position in Savara in Q4 2014 and has held it in 44 quarters since.
186 funds tracked by Wall St. Rank held Savara as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.